22.05.20: Not intended for U.S. and UK Media

Bayer submits larotrectinib for marketing authorization in Japan for the treatment of TRK fusion cancermehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news